PMID: 9174198Jun 1, 1997Paper

Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics

Antimicrobial Agents and Chemotherapy
J D VranyP A Suci

Abstract

Attenuated total reflection Fourier transform infrared spectroscopy was used to measure transport of the fluoroquinolones (FQs) ciprofloxacin and levofloxacin into Pseudomonas aeruginosa biofilms. Biofilms were exposed to each FQ at dose levels of 100, 250, and 500 microg/ml for 30 min. A mathematical transport model was used to extract the diffusion coefficient, binding site density, and adsorption and desorption rates for each experiment. Recalcitrance of the biofilms toward each FQ was evaluated by comparison of efficacies with planktonic bacteria. By this criterion, biofilms were found to exhibit more recalcitrance toward levofloxacin than ciprofloxacin under the experimental conditions. These results cannot be explained by the more hindered transport of levofloxacin, implicating the domination of physiological factors.

References

Jan 1, 1975·Advances in Protein Chemistry·N M Green
May 1, 1976·Immunochemistry·E W VossR T Root
Sep 1, 1975·Antimicrobial Agents and Chemotherapy·G C Crumplin, J T Smith
Aug 1, 1992·Antimicrobial Agents and Chemotherapy·C McCaffreyN H Georgopapadakou
Sep 1, 1992·Antimicrobial Agents and Chemotherapy·B D HoyleJ W Costerton
Nov 1, 1991·Antimicrobial Agents and Chemotherapy·N A Hodges, C A Gordon
Apr 1, 1991·Antimicrobial Agents and Chemotherapy·A F WidmerW Zimmerli
Oct 1, 1989·Antimicrobial Agents and Chemotherapy·H AnwarJ W Costerton
Feb 1, 1989·Antimicrobial Agents and Chemotherapy·D T Chu, P B Fernandes
Oct 1, 1988·Applied and Environmental Microbiology·M W LeChevallierR G Lee
Apr 1, 1988·Antimicrobial Agents and Chemotherapy·J S Chapman, N H Georgopapadakou
Apr 1, 1988·Antimicrobial Agents and Chemotherapy·W W NicholsH L Walmsley
Jun 1, 1987·Antimicrobial Agents and Chemotherapy·R C Evans, C J Holmes
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·J C NickelJ W Costerton
May 24, 1985·Science·A G GristinaC D Hobgood
May 1, 1995·Antimicrobial Agents and Chemotherapy·J BlaserW Zimmerli
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·P A SuciG G Geesey
Jan 1, 1995·Applied and Environmental Microbiology·M L BrownJ J Gauthier
Aug 1, 1993·The Journal of Antimicrobial Chemotherapy·P G Mortimer, L J Piddock
Jan 1, 1993·Journal of Gastroenterology and Hepatology·J Y SungJ W Costerton
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·P S Stewart
Feb 1, 1994·Applied and Environmental Microbiology·G M WolfaardtD E Caldwell
May 1, 1994·Applied and Environmental Microbiology·D R KorberJ W Costerton
Dec 1, 1996·Applied and Environmental Microbiology·S C Nold, D M Ward
May 1, 1994·Biotechnology and Bioengineering·D de BeerZ Lewandowski

❮ Previous
Next ❯

Citations

Mar 21, 2001·Antimicrobial Agents and Chemotherapy·K Lewis
Feb 4, 2003·Nature Reviews. Drug Discovery·David Davies
Feb 10, 2009·Mycopathologia·C Jayampath SeneviratneL P Samaranayake
Sep 13, 2011·Annals of Intensive Care·Christophe Bordi, Sophie de Bentzmann
Jan 10, 2012·Macromolecular Bioscience·Khairul Anuar Mat AminMarc in het Panhuis
Sep 4, 2014·Microbiology and Molecular Biology Reviews : MMBR·David LebeauxChristophe Beloin
Jan 4, 2019·Journal of Medical Microbiology·Attika RehmanIain L Lamont
Dec 11, 2019·Applied Microbiology and Biotechnology·Fazlurrahman KhanYoung-Mog Kim
Sep 3, 1999·Journal of Clinical Pharmacology·M Habash, G Reid
Jun 1, 2007·Clinical Pharmacology and Therapeutics·J L del Pozo, R Patel
Oct 8, 2013·Microbial Ecology·Lawrence R MulcahyKim Lewis
Apr 4, 2017·FEMS Microbiology Reviews·Clayton W Hall, Thien-Fah Mah
Jun 25, 2016·Antibiotics·Tianyan SongSun Nyunt Wai
Apr 14, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Oana CiofuAntonio Oliver
Dec 29, 2004·Biofouling·Lucie MarcotteMichel Lafleur
May 3, 2012·The Journal of Antimicrobial Chemotherapy·Xiaonan LuMichael E Konkel
Oct 2, 2013·Nature Reviews. Drug Discovery·Thomas BjarnsholtNiels Høiby
Aug 13, 2020·Drug Delivery and Translational Research·Ashlee C GreeneSteven R Little
Jun 12, 2013·Environmental Microbiology·Boo Shan TsengMatthew R Parsek
Jan 23, 2020·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Layla AlumutairiMin-Ho Kim
May 26, 2010·FEMS Immunology and Medical Microbiology·Morten HarmsenTim Tolker-Nielsen
May 18, 2017·International Journal of Molecular Sciences·Enea Gino Di DomenicoFabrizio Ensoli
Oct 21, 2020·Physical Review. E·Tadeusz Kosztołowicz, Ralf Metzler
Jan 13, 2021·ACS Infectious Diseases·Rashin Namivandi-ZangenehCyrille Boyer
Jul 14, 1998·Antimicrobial Agents and Chemotherapy·H IshidaH Kobayashi
Jul 18, 2015·Microbiology Spectrum·Philip S Stewart
Aug 15, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·R A Proctor, A von Humboldt
Jan 20, 2021·ACS Biomaterials Science & Engineering·Sudhir K SainiRajesh V Nair
May 21, 1999·Science·J W CostertonE P Greenberg
Feb 4, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Lucía FernándezRobert E W Hancock
Jul 22, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Geraint B RogersGerd Döring

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.